Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study (ANDES)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
AtheroGenics
ClinicalTrials.gov Identifier:
NCT00525577
First received: September 4, 2007
Last updated: February 4, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2008
  Estimated Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)